Haematology MSL

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics seeks an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology trial across Italy and Germany. The role emphasizes scientific engagement with investigators, trial awareness, and compliant exchange within regulatory and SOP frameworks. The candidate will operate across a...

Quetzal Therapeutics is seeking an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology trial across Italy and Germany.Possiede le qualifiche e le competenze giuste per questo lavoro? Lo scopra qui sotto e invii la sua candidatura per essere preso/a in considerazione.This field-based role will engage...

Quetzal Therapeutics is seeking an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology trial across Italy and Germany. This field-based role will engage investigators and treatment centres, support trial awareness, and ensure high-quality scientific exchange within a compliant framework. The successful...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics seeks an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology trial across Italy and Germany. The role emphasizes scientific engagement with investigators, trial awareness, and compliant exchange within regulatory and SOP frameworks. The candidate will operate across a distributed...

Questa posizione è in Menarini Il processo di selezione sarà interamente gestito Menarini. -- Overview This is an exciting opportunity for an experienced Medical Professional looking for a new challenge in an environment where your impact is instantly visible. It is a chance to become an integral member of a small, highly motivated team tasked with...